- Home
- IPHA vs SPCE Comparison
IPHA vs SPCE Comparison
Compare IPHA & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPHA | SPCE |
|---|---|---|
| Founded | 1999 | 2017 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.2M | 226.9M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | IPHA | SPCE |
|---|---|---|
| Price | $1.86 | $2.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | $5.00 | ★ $9.22 |
| AVG Volume (30 Days) | 21.7K | ★ 3.8M |
| Earning Date | 09-17-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $14,839,695.00 | $1,661,000.00 |
| Revenue This Year | $22.29 | N/A |
| Revenue Next Year | $43.90 | $2,656.89 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.47 | $2.18 |
| 52 Week High | $3.51 | $6.82 |
Technical Indicators
Market Signals| Indicator | IPHA | SPCE |
|---|---|---|
| Relative Strength Index (RSI) | 46.44 | 36.28 |
| Support Level | $1.85 | $3.71 |
| Resistance Level | $1.91 | $4.57 |
| Average True Range (ATR) | 0.07 | 0.28 |
| MACD | 0.00 | -0.09 |
| Stochastic Oscillator | 28.54 | 7.05 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.